{
    "eid": "2-s2.0-85114305923",
    "title": "Hiv-1 drug resistance mutations in antiretroviral treated thai patients with low viral load",
    "cover-date": "2019-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Antiretroviral drug resistance",
        "Genotyping",
        "HIV-1",
        "LLV",
        "Low viral load"
    ],
    "authors": [
        "Navin Horthongkham",
        "Kornkanok Prasertsom",
        "Niracha Athipunyasilp",
        "Palanee Ammaranond",
        "Ruengpung Sutthent"
    ],
    "citedby-count": 0,
    "ref-count": 30,
    "ref-list": [
        "Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: A French nationwide study",
        "Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: A 2014 French nationwide study",
        "Prevalence of HIV-1 drug resistance in treated patients AFrench nationwide study",
        "Impact of low-level-viremia on HIV-1 drugresistance evolution among antiretroviral treated-patients",
        "Antiretroviral drug resistance and resistance testing",
        "Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals",
        "Human immunodeficiency virus drug resistance: 2018 recommendations of the international antiviral society-USA panel",
        "Surveillance of HIV-1 drugresistance mutations",
        "Prevalence of genotypic HIV-1 drug resistance",
        "Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial",
        "HIV drug resistance profiles and clinical outcomes in patients with viremia maintained at very low levels",
        "Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia",
        "Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia",
        "Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy",
        "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection",
        "Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse transcrip-tase inhibitor-based first-line regimens in Northern Thailand",
        "Extending HIV drug resistance testing to low levels of plasma viremia",
        "Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels",
        "Prevalence and clinical correlates of HIV viremia (\u2018blips\u2019) in patients with previous suppression below the limits of quantification",
        "A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance",
        "Modifications and substitutions of the RNA extraction module in the ViroSeq\u2122 HIV-1 genotyping system version 2: Effects on sensitivity and complexity of the assay",
        "HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure",
        "Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy",
        "Anti-retroviral treatment of adult HIV infection 2012 recommendations of the International Antiviral Society-USA panel",
        "European recommendations for the clinical use of HIV drug resistance testing: 2011 update",
        "Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions",
        "Successful use of genotypic resistance testing in HIV-1 infection individuals with detectable viraemia between 50 and 1,000 copies/ml",
        "Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Fac ulty of Medicine Siriraj Hospital, Mahidol University"
    ]
}